NasdaqCM - Nasdaq Real Time Price USD
ProKidney Corp. (PROK)
0.8146
+0.0435
+(5.64%)
As of 1:32:05 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-126,351
-126,351
-90,069
-77,089
-50,299
Investing Cash Flow
20,414
20,414
-329,983
-1,738
-5,191
Financing Cash Flow
144,408
144,408
-9,551
548,521
71,470
End Cash Position
99,120
99,120
60,649
490,252
20,558
Income Tax Paid Supplemental Data
73
73
2,857
1,950
68
Capital Expenditure
-29,509
-29,509
-34,197
-1,846
-5,192
Issuance of Capital Stock
144,322
144,322
0
0
--
Issuance of Debt
0
0
0
35,000
0
Repayment of Debt
-54
-54
-52
-35,032
-30
Repurchase of Capital Stock
0
0
-9,499
0
0
Free Cash Flow
-155,860
-155,860
-124,266
-78,935
-55,491
12/31/2021 - 6/30/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SLRN Acelyrin, Inc.
2.1940
+7.29%
ALMS Alumis Inc.
5.33
+18.07%
NAUT Nautilus Biotechnology, Inc.
0.8821
+0.06%
LYEL Lyell Immunopharma, Inc.
0.3991
+2.33%
SPRC SciSparc Ltd.
0.3101
-4.02%
ALXO ALX Oncology Holdings Inc.
0.4328
-5.79%
NRSN NeuroSense Therapeutics Ltd.
1.2100
+0.83%
BCAX Bicara Therapeutics Inc.
13.96
+1.86%
ENVB Enveric Biosciences, Inc.
1.2585
-3.93%
CNTX Context Therapeutics Inc.
0.7580
-4.05%